Prof Linda Mileshkin
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
531 Scholarly works
21 Projects
HIGHLIGHTS
2026
Journal article
Adverse event profile following maintenance olaparib in patients with BRCA-mutated platinum-sensitive relapsed serous ovarian cancer in the phase III SOLO2 trial
DOI: 10.1016/j.ijgc.2026.1045562026
Journal article
ROSELLA (GOG3073, engotov72, APGOT-OV10): a phase 3 study of relacorilant nab-paclitaxel in patients with platinum-resistant ovarian cancer
DOI: 10.1016/j.ijgc.2025.1044262020
Research grants (ARC, NHMRC, MRFF)
Super-Next: Complete Genome Profiling for Cancer of Unknown Primary
2020
Research grants (ARC, NHMRC, MRFF)
Evaluation of Fibroblastic Activation Protein Inhibitors (FAPI) as a Novel Radiopharmaceutical Targeting Cancer-Associated Fibroblasts for the Diagnosis and Treatment of Patients With Cancer of Unknown Primary: The FAPI-CUP Trial
2020
Research Grant
ProTreat: An Adaptive and Rapid Implementation Trial of Novel Therapies to Prevent and Treat COVID19 Infection in High Risk Cancer Patients
2015
Journal article
Whole-genome characterization of chemoresistant ovarian cancer
DOI: 10.1038/nature144102013
Journal article
Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary
DOI: 10.1002/path.4251
RECENT SCHOLARLY WORKS
2026
Journal article
No prognostic role for FIGO grading in mismatch repair deficient endometrial carcinomas
DOI: 10.1016/j.ijgc.2025.1028902026
Journal article
Survival and patterns of failure in small cell neuroendocrine carcinoma of the cervix treated with definitive chemoradiotherapy
DOI: 10.1016/j.ijgc.2025.1028742025
Journal article
762MO Clinical whole genome and transcriptome sequencing for cancer of unknown primary: An Australian prospective observational study
DOI: 10.1016/j.annonc.2025.10.11772025
Journal article
Solving unknown primary cancer with earlier diagnosis - the SUPER-ED trial: study protocol for a stepped-wedge cluster randomised controlled trial to support earlier diagnosis for people presenting with malignancy of undefined primary origin
DOI: 10.1186/s12885-025-13506-42025
Journal article
Introduction to the 2024 Consensus Guidelines for the Management of Neutropenic Fever in Patients with Cancer: Principles & Practice of Neutropenic Fever
DOI: 10.1111/imj.702372025
Journal article
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial
DOI: 10.1097/OGX.00000000000014752025
Journal article
Steering Committee Members.
DOI: 10.1111/imj.703232025
Journal article
EXPLORING TRANSCRIPTIONAL SUBTYPES AND IMMUNE MARKERS IN BEACON; PHASE II STUDY OF ATEZOLIZUMAB, BEVACIZUMAB, COBIMETINIB IN PLATINUM RESISTANT HIGH-GRADE SEROUS OVARIAN CANCER
DOI: 10.1016/j.ijgc.2025.102500